Clinical Trial

A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The trial is designed to evaluate the pharmacokinetics, safety, tolerability, and immunogenicity of AMG 691 in healthy Chinese and Japanese participants
Trial Details
NCT Number NCT07745907
Lead Sponsor Amgen
Conditions Healthy Participants
Enrollment 28 participants
Start Date 2026-08-07
Primary Completion 2027-03-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-04